Accumulating evidence indicated that the key enzyme PDK-1 was involved in metabolic reprogramming of tumors and was highly expressed in types of cancer, such as breast cancer [12], head and neck squamous cancer [13], myeloma [14], gastric cancer [15], and lung cancer [16]. The gene discussed is PDK1; the disease is plasma cell myeloma.